Found 38 matching trials
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis N/A The purpose of this study is to assess whether Multiple Sclerosis patients ...
Show More Location
MS Center at Evergreen Health
Learn More & Join Trial
Kesimpta Pregnancy and Infant Safety Study Using Real World Data N/A The study is an observational retrospective cohort study using longitudinal...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Aerobic Exercises for Multiple Sclerosis NA Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of ...
Show More Location
South Valley University, Faculty of Physical Therapy
Learn More & Join Trial
French Registry for Monitoring Pregnancies for Multiple Sclerosis N/A The influence of pregnancy on the course of multiple sclerosis (MS) has lon...
Show More Learn More & Join Trial
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) PHASE2 To determine the efficacy and safety of an oral drug (BGC20-0134) in patien...
Show More Location
University Hospital Gent
Learn More & Join Trial
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT PHASE3 Primary Objective:
To evaluate the efficacy, safety, and tolerability of a...
Show More Location
Investigational Site Number : 2500001
Learn More & Join Trial
Enhancing Quality of Life in MS Patients Through Tailored Therapeutic Education NA Within the framework of improving the quality of life for patients with Mul...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients N/A This was a retrospective non-interventional study (NIS) of adult (≥18 years...
Show More Learn More & Join Trial
Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis. N/A This was a retrospective cohort study utilizing secondary data from IQVIA's...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS) PHASE2 Multiple Sclerosis (MS) is a chronic inflammatory \& degenerative disease o...
Show More Location
Royal London Hospital
Learn More & Join Trial